Robotic Total Knee Arthroplasty Anesthesia Management

Robotic Total Knee Arthroplasty Anesthesia Management: Retrospective Study

Robotic arthroplasty is increasing in acceptance on a global scale as a result of advancements in orthopedic surgery technology.

The investigators aimed to share our anesthesia management experience as well as compare robotic unilateral total knee arthroplasty with conventional surgical technique in this retrospective study.

Study Overview

• Status: Not yet recruiting
• Conditions: Joint Diseases; Knee Osteoarthritis; Anesthesia
• Intervention / Treatment: Procedure: the robot assisted total knee arthroplasty; Procedure: the conventional jig-based total knee arthroplasty

Detailed Description

This study was approved by the ethics committee of a tertiary academic hospital.

The following criteria were used to assess inclusion: ASA physical status I-III patients aged 40-85 years, elective unilateral total knee arthroplasty (TKAs) performed by a single senior orthopedic surgeon and orthopedic team under combined spinal epidural anesthesia (CSEA) between January 2021 and January 2023. Exclusion criteria included urgent surgery, bilateral surgery, previous surgery, missing data, and being lost to follow-up during the perioperative period. Data was collected from the hospital's electronic database records, patient files, and anesthesia charts.

• Study Type: Observational
• Enrollment (Anticipated): 150

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 40 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients with American Society of Anesthesiologists (ASA) physical status I-III and elective unilateral TKAs between the ages of 40 and 85 will be analyzed.

Description

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) physical status I-III
• Between 40-85 years
• Elective unilateral TKAs which were performed by a single senior orthopedic surgeon
• Between January 2021 and January 2023 under CSEA.

Exclusion Criteria:

• Urgent surgery
• Bilateral surgery
• Previous surgery
• Missing data and lost to follow-up in the perioperative period

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Group rTKA (robotic total knee arthroplasty); the robot assisted total knee arthroplasty	Procedure: the robot assisted total knee arthroplasty; the robot assisted total knee arthroplasty
Group cTKA (conventional total knee arthroplasty); the conventional jig-based total knee arthroplasty	Procedure: the conventional jig-based total knee arthroplasty; the conventional jig-based total knee arthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time	The duration of surgical procedures	Only in surgery time, an average of 3 hours

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Complications	Perioperative complications rates	After the end of surgery, in the first 1-month follow-up
Hospital discharge time	Time from the beginning of the operation to the discharge of hospital	Time from discharge from PACU to discharge from hospital, an average of 96 hours

Collaborators and Investigators

• Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Study record dates

Study Major Dates

• Study Start (Anticipated): April 1, 2023
• Primary Completion (Anticipated): April 1, 2023
• Study Completion (Anticipated): April 1, 2023

Study Registration Dates

• First Submitted: March 7, 2023
• First Submitted That Met QC Criteria: March 17, 2023
• First Posted (Actual): March 30, 2023

Study Record Updates

• Last Update Posted (Actual): April 4, 2023
• Last Update Submitted That Met QC Criteria: April 3, 2023
• Last Verified: April 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Musculoskeletal Diseases; Rheumatic Diseases; Arthritis; Osteoarthritis; Osteoarthritis, Knee; Joint Diseases
• Other Study ID Numbers: 2022-98

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No